Business Description
Trinity Biotech PLC
NAICS : 325413
SIC : 2835
ISIN : US8964383066
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | -0.4 | |||||
Debt-to-Equity | -2.29 | |||||
Debt-to-EBITDA | -2.28 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -1.02 | |||||
Beneish M-Score | -2.91 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.8 | |||||
3-Year Book Growth Rate | -80.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 15 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.39 | |||||
9-Day RSI | 38.56 | |||||
14-Day RSI | 44.59 | |||||
6-1 Month Momentum % | 1.92 | |||||
12-1 Month Momentum % | -51.54 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.6 | |||||
Quick Ratio | 1.27 | |||||
Cash Ratio | 0.25 | |||||
Days Inventory | 209.79 | |||||
Days Sales Outstanding | 88.73 | |||||
Days Payable | 110.93 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -22.4 | |||||
Shareholder Yield % | -0.26 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 34.22 | |||||
Operating Margin % | -28.06 | |||||
Net Margin % | -42.27 | |||||
FCF Margin % | -25.16 | |||||
ROA % | -31.75 | |||||
ROIC % | -28.7 | |||||
ROC (Joel Greenblatt) % | -89.43 | |||||
ROCE % | -42.73 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.14 | |||||
EV-to-EBIT | -3.13 | |||||
EV-to-EBITDA | -3.36 | |||||
EV-to-Revenue | 1.42 | |||||
EV-to-Forward-Revenue | 1.11 | |||||
EV-to-FCF | -5.67 | |||||
Price-to-Median-PS-Value | 0.15 | |||||
Earnings Yield (Greenblatt) % | -31.95 | |||||
FCF Yield % | -83.59 | |||||
Forward Rate of Return (Yacktman) % | -125.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Trinity Biotech PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 52.743 | ||
EPS (TTM) (€) | -4.884 | ||
Beta | 1.13 | ||
Volatility % | 57.37 | ||
14-Day RSI | 44.59 | ||
14-Day ATR (€) | 0.002758 | ||
20-Day SMA (€) | 2.12 | ||
12-1 Month Momentum % | -51.54 | ||
52-Week Range (€) | 1.69 - 4.75 | ||
Shares Outstanding (Mil) | 9.47 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Trinity Biotech PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Trinity Biotech PLC Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Trinity Biotech PLC Frequently Asked Questions
What is Trinity Biotech PLC(FRA:TRB)'s stock price today?
When is next earnings date of Trinity Biotech PLC(FRA:TRB)?
Does Trinity Biotech PLC(FRA:TRB) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |